XML 55 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2015
Fair Value of Financial Instruments

11. Fair Value of Financial Instruments

At September 30, 2015 and December 31, 2014, the carrying amounts of cash equivalents, accounts payable and accrued liabilities approximate fair value because of their short-term nature. All such measurements are Level 2 measurements in the fair value hierarchy. Our marketable securities, consisting of shares of common stock of REGENXBIO, are classified as Level 1 assets as they have readily observable prices, and therefore a reliable fair market value as of September 30, 2015. The fair value of the convertible notes, which differs from their carrying value, is influenced by interest rates and stock price and stock price volatility and is determined by prices for the convertible notes observed in market trading. The market for trading of the convertible notes is not considered to be an active market and therefore the estimate of fair value is based on Level 2 inputs. The estimated fair value of the convertible notes, face value of $200 million, was $196.9 million at September 30, 2015 and $203.4 million at December 31, 2014, respectively.